Vicapsys Life Sciences Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
2
- Stock Symbol
-
VICP
- Investments
-
2
- Share Price
-
$0.50
- (As of Wednesday Closing)
Vicapsys Life Sciences General Information
Description
Vicapsys Life Sciences Inc is a biotech company that is engaged in commercializing implantable medical products that incorporate VICAPSYN, inducing a zone of immuno-protection around devices and cells implanted in the human body. The product VICAPSYN is the company's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field.
Contact Information
Website
www.vicapsys.comCorporate Office
- 7778 Mcginnis Ferry Road
- Suite 270
- Suwanee, GA 30024
- United States
Corporate Office
- 7778 Mcginnis Ferry Road
- Suite 270
- Suwanee, GA 30024
- United States
Vicapsys Life Sciences Stock Performance
As of 04-Nov-2026, Vicapsys Life Sciences’s stock price is $0.50. Its current market cap is $16.2M with 32.4M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.50 | $0.50 | $0.10 - $1.75 | $16.2M | 32.4M | 3.87K |
Vicapsys Life Sciences Financials Summary
As of 30-Sep-2024, Vicapsys Life Sciences has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 224,753 | 88,129 | 34,849 | |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (1,257) | (1,162) | (954) | (206) |
| Net Income | (1,347) | (1,182) | (985) | (237) |
| Total Assets | 90 | 40 | 72 | 594 |
| Total Debt | 579 | 354 | 0 |
Vicapsys Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Vicapsys Life Sciences Signals
Vicapsys Life Sciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Vicapsys Life Sciences Acquisitions (2)
Vicapsys Life Sciences’s most recent deal was a Merger/Acquisition with Surge Solutions Group. The deal was made on 26-Dec-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Surge Solutions Group | 26-Dec-2017 | Merger/Acquisition | Environmental Services (B2B) | ||
| B&M Construction | 18-May-2010 | Merger/Acquisition | Construction and Engineering |
Vicapsys Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Vicapsys Life Sciences FAQs
-
When was Vicapsys Life Sciences founded?
Vicapsys Life Sciences was founded in 1996.
-
Where is Vicapsys Life Sciences headquartered?
Vicapsys Life Sciences is headquartered in Suwanee, GA.
-
What is the size of Vicapsys Life Sciences?
Vicapsys Life Sciences has 2 total employees.
-
What industry is Vicapsys Life Sciences in?
Vicapsys Life Sciences’s primary industry is Biotechnology.
-
Is Vicapsys Life Sciences a private or public company?
Vicapsys Life Sciences is a Public company.
-
What is Vicapsys Life Sciences’s stock symbol?
The ticker symbol for Vicapsys Life Sciences is VICP.
-
What is the current stock price of Vicapsys Life Sciences?
As of 04-Nov-2026 the stock price of Vicapsys Life Sciences is $0.50.
-
What is the current market cap of Vicapsys Life Sciences?
The current market capitalization of Vicapsys Life Sciences is $16.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process